Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC23H22ClN3O5S |
InChIKeyJVAPIYLPNKDKAQ-KGLIPLIRSA-N |
CAS Registry1150098-10-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | IT | 02 Jul 2024 |